TURNSTONE BIOLOGICS CORP (TSBX) Forecast, Price Target & Analyst Ratings

NASDAQ:TSBX • US90042W1009

Current stock price

0.355 USD
+0.01 (+1.43%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TURNSTONE BIOLOGICS CORP (TSBX).

Forecast Snapshot

Consensus Price Target

Price Target
$1.02
+ 187.32% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2025
EPS Estimate
-$0.14
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.02
Upside
+ 187.32%
From current price of $0.36 to mean target of $1.02, Based on 6 analyst forecasts
Low
$1.01
Median
$1.02
High
$1.05

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for TSBX. The average price target is 1.02 USD. This implies a price increase of 187.32% is expected in the next year compared to the current price of 0.355.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TSBX Current Analyst RatingTSBX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

TSBX Historical Analyst RatingsTSBX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
TSBX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TSBX.
In the previous month the buy percentage consensus was at a similar level.
TSBX was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-10-14B of A SecuritiesDowngrade Buy -> Neutral
2024-08-19B of A SecuritiesMaintains Buy -> Buy
2024-08-19Piper SandlerMaintains Overweight -> Overweight
2023-08-15B of A SecuritiesInitiate Buy
2023-08-15Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2025
EPS Estimate
-$0.14
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
80.70%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TSBX revenue by date.TSBX revenue by date.
101.293M73.3M
-27.64%		19.306M
-73.66%
-100.00%
EBITDA
YoY % growth
TSBX ebitda by date.TSBX ebitda by date.
34.383M-27.725M
-180.64%		-56.234M
-102.83%		-81.569M
-25.65%		-60.782M
13.98%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TSBX ebit by date.TSBX ebit by date.
32.993M-31.626M
-195.86%		-59.032M
-86.66%		-78.642M
-22.80%		-16.422M
77.35%		-12.75M
22.36%		-139.536M
-994.40%		-8.16M
94.15%		-223.38M
-2,637.50%		-169.32M
24.20%		-139.74M
17.47%		131.58M
194.16%
Operating Margin
TSBX operating margin by date.TSBX operating margin by date.
32.57%-43.15%-305.77%N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
TSBX eps by date.TSBX eps by date.
N/AN/AN/A-3.27
49.04%		-0.70
77.07%		-0.52
26.09%		N/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth		-0.14
80.70%		-0.13
76.32%		-0.13
74.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-3.264M
82.23%		-3.06M
73.11%		N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TSBX Yearly Revenue VS EstimatesTSBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 20M 40M 60M 80M 100M
TSBX Yearly EPS VS EstimatesTSBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TURNSTONE BIOLOGICS CORP / TSBX Forecast FAQ

What is the average price target for TURNSTONE BIOLOGICS CORP (TSBX) stock?

6 analysts have analysed TSBX and the average price target is 1.02 USD. This implies a price increase of 187.32% is expected in the next year compared to the current price of 0.355.

What are the consensus estimates for TSBX stock next earnings?

The consensus EPS estimate for the next earnings of TURNSTONE BIOLOGICS CORP (TSBX) is -0.14 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for TSBX stock?

The number of analysts covering TURNSTONE BIOLOGICS CORP (TSBX) is 6.